Zentalis Pharmaceuticals

ZNTLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$300.406 M

$4.22 -15.60%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$137.1M

Loss-making

Shares outstanding

71,671,914

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#234Opus GeneticsIRD$302.2M
#235Vanda PharmaceuticalsVNDA$300.7M
#236Zentalis PharmaceuticalsZNTL$300.4M
#237Fulcrum TherapeuticsFULC$296.8M
#238Bicycle TherapeuticsBCYC$291.9M

Where these numbers come from

Share counts and financials for Zentalis Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.